Revenue segments as reported by the company.

Premiums

Services

Investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefits

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Humana

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental plans such as Medicare, and State-based contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance. The Healthcare Services segment offers services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics to other Humana businesses, as well as external health plan members, and other employers. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Humana exceeds earnings expectations, focuses on value-based care growth

Humana's strong financial performance and growth in value-based care position the company well for future success. Addressing audit error rates, uncertainties around RADV, and managing costs are key challenges. Opportunities in recruiting, revenue growth, and strategic partnerships offer avenues for further growth.

Humana exceeds Q1 expectations, eyes industry growth amidst challenges

Humana's strong Q1 performance and strategic decisions position it well for growth
Challenges like rate disruptions and Medicaid redeterminations require close monitoring
Opportunities in industry growth, member engagement, and benefit enhancements ahead
Commitment to long-term goals and high-quality service evident in company's outlook

Humana meets Q2 expectations, eyes growth in MA platform

Humana's Q2 performance met expectations with a focus on MA platform growth and disciplined investments.
Challenges include higher utilization in Medicare Advantage and broad-based medical cost trends.
Strategic benefits adjustments and competitive positioning present opportunities for growth and margin expansion.
Expectations for 2024 include maintaining market share, offsetting costs, and achieving strong membership growth.

Humana surpasses Q3 earnings expectations, eyes $37 EPS target

Humana's Q3 performance exceeded expectations, with strong membership growth and strategic initiatives driving future profitability.
While facing challenges in benefit ratios and regulatory changes, Humana remains focused on achieving long-term financial targets.
The company's commitment to operational excellence, membership growth, and pricing actions positions it for sustained success.
Strategic partnerships and risk management efforts showcase Humana's resilience and adaptability in a dynamic healthcare landscape.

Humana faces challenges from rising costs but eyes long-term growth

Humana's Q4 2023 earnings call highlighted challenges from increased medical costs and utilization trends impacting financial performance and outlook.
Despite disappointments in short-term results, the company remains confident in the long-term attractiveness of the Medicare Advantage sector.
Strategic efforts to restore margins, address utilization drivers, and engage with providers reflect a proactive approach to managing industry dynamics.
Balancing profitability with membership growth through benefit adjustments and pricing actions is crucial for Humana's sustainable financial performance.

Humana reports solid Q1 performance, eyes margin recovery in 2025

Humana's Q1 2024 earnings call highlighted a strong start to the year, challenges in the industry for 2025, and a focus on margin recovery and growth opportunities. The company remains confident in its outlook, emphasizing pricing discipline and maintaining a strong value proposition in the market.

Humana surpasses Q2 expectations, addresses cost pressures for growth

Humana's Q2 2024 performance exceeded expectations, driven by strong Medicare business and growth in Medicaid and primary care segments.
Challenges such as medical cost pressures were addressed through mitigation measures, while opportunities lie in strategic initiatives and long-term planning.
The company's focus on value, disciplined cost management, and operational efficiency position it well for sustained growth and value creation.

Humana surpasses Q3 expectations, eyes growth through efficiency and investments

Humana's Q3 performance exceeded expectations, with a focus on balancing earnings and investments. The company is strategically positioned to drive growth through membership expansion and operational efficiency. Challenges include managing costs and understanding market dynamics, with opportunities in improving Stars ratings and expanding senior care services.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

LOUISVILLLE, Ky.--(BUSINESS WIRE)--Humana Launches Humana Care Support Pilot to Help Medicare Advantage Members to Better Manage Their Chronic Conditions

Humana Launches Humana Care Support Pilot to Help Medicare Advantage Members to Better Manage Their Chronic Conditions

Ally Financial

Citizens Financial Group

Disney

Johnson & Johnson

New Linde PLC

Mastercard

Simon Property Group

T-Mobile US

The bank thinks the broader market could be flat through year's end, but that doesn't mean there won't be big winners.

10 Stock Picks For Investors Worried About Sky-High Tech Valuations, According To Morgan Stanley

Anthem

Merck

UnitedHealth Group

Vertex Pharmaceuticals

With the markets setting all-time highs again and the first quarter soon to begin winding down, investors may be pondering how to position themselves for the rest of the year.

5 Health Care Laggards With Healthy Upside Potential

Humana (HUM) teams up with IBM Watson Health to leverage the latter's conversational AI solution for providing better information to Humana Employer Group members.

Humana (HUM) Joins IBM Watson Health to Aid Member Experience

LOUISVILLE, Ky. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Humana and IBM Watson Health Collaborate to Simplify and Enhance the Member Experience for Humana Employer Group Customers

Humana and IBM Watson Health Collaborate to Simplify and Enhance the Member Experience for Humana Employer Group Customers

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Begins Coverage of Hospice Services as Part of Medicare Demonstration

Humana Begins Coverage of Hospice Services as Part of Medicare Demonstration

Change Healthcare Inc

Signify Health has filed proposed terms for its U.S. IPO. The firm provides a platform to increased healthcare system efficiencies through value-based care.

Signify Health Pursues $423 Million IPO

Humana Inc. (HUM) CEO Bruce Broussard on Q4 2020 Results - Earnings Call Transcript

Humana's (HUM) fourth-quarter results reflect elevated costs related to COVID-19 along with high marketing expenses.

Humana's (HUM) Q4 Loss Narrower Than Expected, Tumble Y/Y

Humana reported a $458 million fourth quarter loss as the health insurer was hit by costs related to the Covid-19 pandemic and the expense of testing and treating these patients in the last two months of 2020.

Humana Hit Hard By Covid-19 Costs As Medicare Advantage Enrollment Rises

Shares of Humana (NYSE:HUM) remained unaffected after the company reported Q4 results. Quarterly Results Earnings per share fell 200.88% over the past year to ($2.30), which beat the estimate of ($2.36).

Humana: Q4 Earnings Insights

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and results per common share for the quarter ended December 31, 2020 (4Q20) versus the quarter ended December 31, 2019 (4Q19) and for the year ended December 31, 2020 (FY 2020) versus the year ended December 31, 2019 (FY 2019) as noted in the tables below. Consolidated (loss) income before income taxes and equity in earnings (pretax (loss) income) In millions 4Q20 (a)   4Q19 (b) FY 2020 (c)   FY

Humana Reports Fourth Quarter 2020 Financial Results; Provides Full Year 2021 Financial Guidance

Humana's (HUM) fourth-quarter 2020 earnings might have endured escalating COVID-related expenses, partly offset by better revenues.

Humana (HUM) to Report Q4 Earnings: What's in the Cards?

DENVER & LOUISVILLE, Ky.--(BUSINESS WIRE)--DispatchHealth and Humana Team Up to Provide Hospital-Level Care in the Home

DispatchHealth and Humana Team Up to Provide Hospital-Level Care in the Home

OKLAHOMA CITY--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) has been selected by the Oklahoma Health Care Authority (OHCA) to deliver health care coverage to Medicaid beneficiaries across the state, starting later this year. Humana's Medicaid division, Humana Healthy Horizons, will administer the coverage in Oklahoma. Through SoonerSelect, the Oklahoma Medicaid managed care program – focused on Temporary Assistance for Needy Families, the Children's Health Insu

Humana Selected by Oklahoma Health Care Authority to Serve Medicaid Beneficiaries

LOUISVILLE, Ky.--(BUSINESS WIRE)--The South Carolina Department of Health and Human Services (SCDHHS) has added Humana Inc. (NYSE: HUM) to its Healthy Connections Medicaid program and its Healthy Connections Prime program to serve children and adults across the state, including residents dually eligible for Medicaid and Medicare. Humana will begin enrolling new Healthy Connections Medicaid members on July 1, 2021, followed by new Healthy Connections Prime members beginning January 1, 2022. Heal

Humana to Begin Serving Medicaid Managed Care and Dual Eligible Residents in South Carolina

LOUISVILLE, Ky.--(BUSINESS WIRE)--Go365® by Humana Announces Winners of Third Annual National Step Challenge, Resulting in 8.6 Billion Steps Taken and One Million Meals Donated

Go365® by Humana Announces Winners of Third Annual National Step Challenge, Resulting in 8.6 Billion Steps Taken and One Million Meals Donated to Feeding America®

NASHVILLE, Tenn., Jan. 26, 2021 /PRNewswire/ -- Monogram Health announced today that it is expanding its collaboration with leading health and wellness company Humana Inc. (NYSE: HUM). Through an agreement now in effect, Monogram is providing care coordination services in Alabama and...

Monogram Health Announces Availability of Kidney Disease Care Coordination Services for Humana Members in Tennessee and Alabama

Hello, Happy Monday! We're starting off the day with some fresh vaccine news. First, Merck is discontinuing its COVID-19 vaccine trials, a major setback from the company that developed the only Ebola vaccine.

The next wave of vaccines — Humana's answer to buzzy startups — Calico's hiring

LOUISVILLE, Ky.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) has named Nwando Olayiwola, M.D., MPH, FAAFP, to the position of Senior Vice President and Chief Health Equity Officer. In this newly created role, Dr. Olayiwola will report directly to Humana Chief Medical and Corporate Affairs Officer William Shrank, M.D., and will set direction and establish strategy to promote health equity across all Humana lines of business, including its care delivery assets.

Humana Names Nwando Olayiwola, M.D., Chief Health Equity Officer

Caledonia Mining

Jewett-Cameron Trading

Worthington Industries

According to the All-in-one Screener, a Premium feature of GuruFocus, four Peter Lynch Growth stocks with high cash-to-debt ratios are Caledonia Mining Corp. PLC (CMCL), Humana Inc. (NYSE:HUM), Jewett-Cameron Trading Co. Ltd. (NASDAQ:JCTCF) and Worthington Industries Inc. (NYSE:WOR).

4 Peter Lynch Growth Stocks With Good Financial Strength

AUSTIN, Texas--(BUSINESS WIRE)--Humana Healthy Horizons and The Humana Foundation commit more than $2.5 million to COVID-19 relief in Texas.

Humana Healthy Horizons and The Humana Foundation Commit More Than $2.5 Million to COVID-19 Relief in Texas

WATERTOWN, Mass. & LOUISVILLE, Ky.--(BUSINESS WIRE)--Collaboration integrates Humana's value-added member insights within athenahealth's EHR to support provider decision-making at point of care.

athenahealth and Humana Collaborate to Improve Healthcare Outcomes for its Members

COLUMBUS, Ohio--(BUSINESS WIRE)--Humana partners with leading Ohio nonprofits to address food insecurity and housing.

Humana Partners with Leading Ohio Nonprofits to Address Food Insecurity and Housing

Biogen

CVS Health

Universal Health Services

As the Covid-19 vaccines from Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) continue to be distributed throughout the U.S. and internationally to doctors, nurses, the elderly and other vulnerable populations, investors are looking to the health care industry to find value.

News for Humana Stock (HUM)